Q2 Earnings Estimate for DocGo Issued By Northland Capmk

Key Points

• Northland Capmk has issued Q2 2026 earnings estimates for DocGo Inc., predicting earnings of $0.01 per share, while the full-year estimate stands at $0.25 per share.
• The stock has faced negative revisions from analysts, with Canaccord Genuity cutting its price target from $5.00 to $1.45 and Needham decreasing theirs from $4.00 to $3.00.
• DocGo shares are trading down by 2.5%, with a current market price of $1.53 and a market capitalization of $156.03 million.

DocGo Inc. (NASDAQ:DCGO - Free Report) - Research analysts at Northland Capmk issued their Q2 2026 EPS estimates for DocGo in a report released on Monday, August 11th. Northland Capmk analyst M. Latimore expects that the company will post earnings of $0.01 per share for the quarter. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.03 EPS and FY2026 earnings at $0.04 EPS.

Other analysts have also recently issued reports about the stock. Canaccord Genuity Group restated a "hold" rating and set a $1.45 price target (down from $5.00) on shares of DocGo in a research note on Monday, May 12th. Needham & Company LLC decreased their target price on shares of DocGo from $4.00 to $3.00 and set a "buy" rating on the stock in a report on Friday, May 9th. Finally, BTIG Research lowered shares of DocGo from a "buy" rating to a "neutral" rating in a report on Friday, May 9th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, DocGo presently has an average rating of "Moderate Buy" and an average target price of $3.56.

DocGo Trading Down 2.5%

Shares of DCGO stock opened at $1.53 on Tuesday. The stock has a market capitalization of $156.03 million, a P/E ratio of -8.05 and a beta of 0.96. The firm's 50 day moving average is $1.51 and its 200 day moving average is $2.46. DocGo has a 12 month low of $1.23 and a 12 month high of $5.68.

DocGo (NASDAQ:DCGO - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported ($0.11) EPS for the quarter, missing analysts' consensus estimates of ($0.06) by ($0.05). The business had revenue of $80.42 million for the quarter, compared to analysts' expectations of $77.58 million. DocGo had a negative net margin of 4.20% and a negative return on equity of 3.19%.

Institutional Trading of DocGo

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Vanguard Group Inc. grew its stake in DocGo by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 5,014,375 shares of the company's stock worth $21,261,000 after buying an additional 14,454 shares in the last quarter. P.A.W. Capital Corp grew its stake in DocGo by 60.0% in the 2nd quarter. P.A.W. Capital Corp now owns 3,200,000 shares of the company's stock worth $5,024,000 after buying an additional 1,200,000 shares in the last quarter. S Squared Technology LLC grew its stake in DocGo by 52.2% in the 2nd quarter. S Squared Technology LLC now owns 2,878,286 shares of the company's stock worth $4,519,000 after buying an additional 987,310 shares in the last quarter. Punch & Associates Investment Management Inc. grew its stake in DocGo by 17.4% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock worth $5,812,000 after buying an additional 325,760 shares in the last quarter. Finally, Jefferies Financial Group Inc. grew its stake in DocGo by 6,874.1% in the 1st quarter. Jefferies Financial Group Inc. now owns 2,029,456 shares of the company's stock worth $5,358,000 after buying an additional 2,000,356 shares in the last quarter. Institutional investors own 56.44% of the company's stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.